Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lixue Xuan"'
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
ObjectiveBreast cancer is highly heterogeneous, presenting challenges in prognostic assessment. Developing a universally applicable prognostic model could simplify clinical decision-making. This study aims to develop and validate a novel breast cance
Externí odkaz:
https://doaj.org/article/cace6f5ae7844fb0b9f2f8b8b45b993d
Autor:
Kexin Feng, Shuangtao Zhao, Qingyao Shang, Guangdong Qiao, Jiaxiang Liu, Chenxuan Yang, Ya Wei, Yalun Li, Fei Ren, Lixue Xuan, Xiang Wang, Xin Wang
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background Due to the rarity of PBL and the lack of large-scale studies, the prognostic value of IPI in PBL was controversial. Especially in the rituximab era, the ability of IPI to stratify prognosis in patients receiving immunochemotherapy
Externí odkaz:
https://doaj.org/article/7f2b648d9b8347708b3ead9a9b32cc9d
Autor:
Ke Zhang, Yuan Li, Xiangyi Kong, Chuqi Lei, Huaiyu Yang, Nianchang Wang, Zhongzhao Wang, Hu Chang, Lixue Xuan
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
AGR2 is a secreted protein widely existing in breast. In precancerous lesions, primary tumors and metastatic tumors, the expression of AGR2 is increased, which has aroused our interest. This review introduces the gene and protein structure of AGR2. I
Externí odkaz:
https://doaj.org/article/5a4135ea5a484eacb9838d6d5d2da91c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Autoimmune diseases and malignant tumors are the two hotspots and difficulties that are currently being studied and concerned by the medical field. The use of PD-1/PD-L1 inhibitors improves the prognosis of advanced tumors, but excessive immune respo
Externí odkaz:
https://doaj.org/article/032644af7a0b47b19d64d974271d81c5
Autor:
Zhuanbo Yang, Xiaowen Lan, Zhou Huang, Yong Yang, Yu Tang, Hao Jing, Jianyang Wang, Jianghu Zhang, Xiang Wang, Jidong Gao, Jing Wang, Lixue Xuan, Yi Fang, Jianming Ying, Yexiong Li, Xiaobo Huang, Shulian Wang
Publikováno v:
Breast, Vol 53, Iss , Pp 143-151 (2020)
Objective: To develop a nomogram for predicting the possibility of four or more positive nodes in breast cancer patients with 1–3 positive sentinel lymph nodes (SLN). Materials and methods: Retrospective analysis of data of patients from two instit
Externí odkaz:
https://doaj.org/article/0852d6a206d8464588e6509d666b9e30
Autor:
Tingting Zuo, Hongmei Zeng, Huichao Li, Shuo Liu, Lei Yang, Changfa Xia, Rongshou Zheng, Fei Ma, Lifang Liu, Ning Wang, Lixue Xuan, Wanqing Chen
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-10 (2017)
Abstract Background Stage at diagnosis and molecular subtype are important clinical factors associated with breast cancer patient survival. However, subgroup survival data from a large study sample are limited in China. To estimate the survival diffe
Externí odkaz:
https://doaj.org/article/385e2b20cc614529bcab7fc5ce7595f3
Publikováno v:
Journal of Cellular and Molecular Medicine
Breast cancer, a hormone‐dependent tumour, generally includes four molecular subtypes (luminal A, luminal B, HER2 enriched and triple‐negative) based on oestrogen receptor, progesterone receptor and human epidermal growth factor receptor‐2. Mul
Publikováno v:
Progress in Natural Science: Materials International, Vol 30, Iss 5, Pp 555-566 (2020)
The morphology of nanomaterials combines the characteristics of their size, shape and spatial structure. Owing to the improved spatiotemporal control of the nanocarriers for anti-cancer drug delivery, the morphology adaptive nanomaterials have receiv
Autor:
Jing Wang, Hao Jing, Shulian Wang, Zhou Huang, Jidong Gao, Yi Fang, Yexiong Li, Jianming Ying, Yong Yang, Zhuanbo Yang, Xiang Wang, Yu Tang, Lixue Xuan, Xiaowen Lan, Jianyang Wang, Xiaobo Huang, Jianghu Zhang
Publikováno v:
Breast, Vol 53, Iss, Pp 143-151 (2020)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Objective To develop a nomogram for predicting the possibility of four or more positive nodes in breast cancer patients with 1–3 positive sentinel lymph nodes (SLN). Materials and methods Retrospective analysis of data of patients from two institut
Publikováno v:
Journal of cellular and molecular medicine. 26(5)
Triple-negative breast cancer (TNBC), a heterogeneous tumour that lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), is often characterized by aggressiveness and tends to r